[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-469991-105":59,"doc-detail-469991-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","imaging-based-biological-staging-associates-with-brain-atrophy-in-preclinical-alzheimers-disease","Imaging-based biological staging associates with brain atrophy in preclinical Alzheimer’s disease","","Alzheimer’s disease staging relies on imaging biomarkers, with cortical brain atrophy as a key marker of progression, yet cortical atrophy rates in preclinical stages are insufficiently characterized. In 162 amyloid β-positive, asymptomatic individuals from the A4 Study, baseline MRI and amyloid/tau PET and follow-up MRI at least two years later were used to test associations between an imaging-based biological AD staging framework and longitudinal cortical atrophy patterns. Tau PET positivity was defined using SUVR thresholds derived from an independent Aβ-negative LEARN sample.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/imaging-based-biological-staging-associates-with-brain-atrophy-in-preclinical-alzheimers-disease/469991/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/imaging-based-biological-staging-associates-with-brain-atrophy-in-preclinical-alzheimers-disease/469991.png","ImageObject",300,407,{"name":92,"@type":93},"MrHarris58","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What imaging modalities and biomarkers were used to define biological AD staging?","Question",{"text":112,"@type":113},"The study used MRI and PET biomarkers for amyloid-β (18F-Florbitapir) and tau (18F-Flortaucipir). Tau positivity was assessed in the medial temporal lobe and neocortex using SUVR thresholds.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were tau positivity thresholds determined for the PET analyses?",{"text":117,"@type":113},"Tau positivity was defined as SUV ratio 2.5 standard deviations above the mean derived from a separate population of 55 Aβ-negative individuals from the LEARN substudy.",{"name":119,"@type":110,"acceptedAnswer":120},"What was the main relationship between staging and brain atrophy?",{"text":121,"@type":113},"Imaging-based biological AD staging was closely associated with cortical brain atrophy, showing accelerated rates of cortical atrophy across stages and suggesting temporoparietal volumetric serial measures as early progression biomarkers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},469991,1792833493,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":19,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":52,"preview_page_count":19,"preview_urls":144},687212988360,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","DOI: 10. 1002/alz70856_107663  \nBIOMARKERS  \nPOSTER PRESENTATION  \nNEUROIMAGING  \nImaging-based biological staging associates with brain atrophy in preclinical Alzheimer’s disease  \nLorenzo Fontura Brasil Barcellos1  João Pedro Ferrari-Souza2, 3   \nIsabela Just de Jesus Vanni 1  Marco Antônio Albini Valer4  Andrei Bieger Sr.1  Douglas Teixeira Leffa2  Firoza Z Lussier2  Wagner S. Brum 1  Cristiano Aguzzoli5 Anderson Corin6  Marco Antônio De Bastiani3  Giovanna Carello-Collar3  Wyllians Vendramini Borelli 1  Nesrine Rahmouni7  Joseph Therriault7   \nLydia Trudel7  Arthur C. Macedo7 Bruna Bellaver2  Diogo O. Souza3 Eduardo R. Zimmer3  \nPamela C. L. Ferreira2 Pedro Rosa-Neto7   \n Guilherme Povala2 Tharick A Pascoal2   \n1 Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil  \n2 University of Pittsburgh, Pittsburgh, PA, USA  \n3 Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil  \n4 Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil  \n5 Neurology Department, São Lucas Hospital of PUCRS, Porto Alegre, Rio Grande do Sul, Brazil  \n6 Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, Brazil  \n7 McGill University, Montreal, QC, Canada  \nCorrespondence  \nLorenzo Fontura Brasil Barcellos, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.  \nEmail: [lorenzo.f.barcellos@gmail.com](lorenzo.f.barcellos@gmail.com)  \nAbstract  \nBackground: Alzheimer’s disease (AD) diagnostic and staging criteria rely on imaging biomarkers as robust tools for in vivo disease assessment. Among these, cortical brain atrophy is recognized as a key hallmark of disease progression. However, rates of cortical atrophy in preclinical stages remain insufficiently explored within current staging frameworks. In a group of amyloid β-positive (Aβ+) asymptomatic individuals, we investigated the association of the imaging-based biological AD staging framework with longitudinal brain atrophy patterns.  \nMethods: We included 162 Aβ+ participants from the A4 Study placebo group with available magnetic resonance imaging (MRI) and positron emission tomography (PET) for amyloid-β (Aβ) plaques ([18 F]Florbetapir) and tau ([18 F]Flortaucipir) at baseline, along with a follow-up MRI at least 2 years after baseline. Tau positivity in the medial temporal lobe (TMTL +) and in the neocortex (TNEO +) were determined as tau PET standardized uptake value ratio (SUVR) of 2.5 standard deviations above the mean derived from a separate population (LEARN substudy) of 55 Aβ-negative individuals. Groups were compared using analysis of covariance (ANCOVA) with Tukey’s multiple comparison test, adjusting for relevant covariates.  \nResults: Demographic characteristics of the population are displayed in Table 1. In cross-sectional analysis, we observed that baseline cortical gray matter volumes differed significantly only between A+TNEO + and A+T − groups (p = 0.042), with  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2025 The Alzheimer’s Association. Alzheimer’s & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer’s Association.  \nAlzheimer’s Dement. 2025;21(Suppl. 2):e107663.  \n[https://doi.org/10.1002/alz70856_107663](https://doi.org/10.1002/alz70856_107663)  \nwi[leyonlinelibrary.com/journal/alz](leyonlinelibrary.com/journal/alz)  \n1of4  \nBIOMARKERS  \nno significant differences between other groups (p >0.05 for both; Figure 1a). Longitudinally, A+TNEO + individuals exhibited greater rates of cortical atrophy compared to A+T − (p \u003C0.001) and A+TMTL + (p = 0.007), along with A+TMTL + individuals showing higher rates of cortical atrophy compared to the A+T − group (p = 0.042; Figure 1b). Subsequent regional analyses revealed that the A+TNEO + individuals showed higher atrophy compared to both A+T− a","cbCaibNkGTiKHrVP","https://ap.wps.com/l/cbCaibNkGTiKHrVP","pdf",1281434,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions","[{\"question\":\"What imaging modalities and biomarkers were used to define biological AD staging?\",\"answer\":\"The study used MRI and PET biomarkers for amyloid-β (18F-Florbitapir) and tau (18F-Flortaucipir). Tau positivity was assessed in the medial temporal lobe and neocortex using SUVR thresholds.\"},{\"question\":\"How were tau positivity thresholds determined for the PET analyses?\",\"answer\":\"Tau positivity was defined as SUV ratio 2.5 standard deviations above the mean derived from a separate population of 55 Aβ-negative individuals from the LEARN substudy.\"},{\"question\":\"What was the main relationship between staging and brain atrophy?\",\"answer\":\"Imaging-based biological AD staging was closely associated with cortical brain atrophy, showing accelerated rates of cortical atrophy across stages and suggesting temporoparietal volumetric serial measures as early progression biomarkers.\"}]","Imaging-based biological staging associates with brain atrophy in preclinical Alzheimer’s disease | PDF",1790776539,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/0880ae850e878432423f725e1c0420a7.webp",983,1291,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/0877277fcab94aad66a42db29155d321.webp",982,1290,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/d8c297733fe0ad57a8ac690f90baf6d4.webp",981,1289,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/141d77efb78633a4e1015623e2c86ffc.webp",980,1287]